Inhibition of endotoxin-induced hepatotoxicity by melatonin in rats

International Journal of Biomedical Science

Volumn 4, Issue 2, 2008, Pages 103-112

  Rishi, Praveen ^a   Bharrhan, Sushma ^a   Bhalla, Manmeet Pal Singh ^a   Koul, Ashwani ^a   Chopra, Kanwaljit ^b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Endotoxin; Liver; Melatonin; Necrosis; Oxidative stress; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CATALASE; ENDOTOXIN; GLUTATHIONE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MELATONIN; PINEAL BODY HORMONE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENDOTOXEMIA; FEMALE; HISTOPATHOLOGY; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER TOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; WISTAR RAT;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; RATTUS NORVEGICUS;

EID: 67650389922     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wan JM, Sit WH, Lee CL, Fu KH, et al. Protection of lethal toxicity of endotoxin by Salvia milliarrhiza BUNGE is via reduction in tumor necrosis factor alpha release and liver injury. Int Immunopharmacol. 2006; 6: 750.
2. Danner RL, Elin RJ, Hossein JM, Wesley RA, et al. Endotoxemia in human septic shock. Chest. 1991; 99: 169.
3. Barron RL. Pathophysiology of septic shock and implications for therapy. Clin Pharm. 1993; 12: 829.
4. Jaeschke H, Gores JG, Hinson JA. Mechanisms of hepatotoxicity. Toxicol Sci. 2005; 65: 166.
5. Borzotta AP, Polk HC. Jr. Multiple system organ failure. Surg Clin North Am. 1993; 63: 315.
6. Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis. 1992; 15: 840.
7. Nistico G, Fiskin D, Iannone M, DeMartino A. et al. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radic Bio Med. 1992; 12: 177.
8. Teixeira A, Morfim MP, de Cordova CA, Charao CC, et al. Melatonin protects against pro-oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite. J Pineal Res. 2003; 35: 262.
9. Wang H, Wei W, Shen YX, Dong C, et al. Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus Lipopolysaccharide. World J Gastroenterol. 2004; 10: 2690.
10. Reiter RJ, Tan DX, Mayo JC, Sainz RM, et al. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol. 2003; 50: 1129.
11. Rodriguez C, Mayo JC, Sainz RM, Antolin I, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004; 36: 1.
12. Sewerynek E, Reiter RJ, Lewinski A. Lipopolysaccharide induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol. 1995; 293: 327.
13. Crespo E, Pozo D, Martin M. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB. 1999; 13: 1537.
14. Wu CC, Chiao CW, Hsiao G, Chen A, et al. Melatonin prevents endotoxin-induced circulatory failure in rats. J Pineal Res. 2001; 30: 147.
15. Sener G, Toklu H, Kapucu C, Ercan F, et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today. 2005; 35: 52.
16. Escames G, Acuna-Castroviejo D, Lopez LC, Tan DX, et al. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol. 2006; 58: 1153.
17. Wang H, Xu, DX, Lv JW, Ning H, et al. Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D- galactosamine- sensitized mice. Toxicol. 2007; 237: 49.
18. Wills ED. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 1966; 99: 667.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin's phenol reagent. J Biol Chem. 1951; 193: 265.
20. Jollow D, Mitchell L, Zampaglione N, Gillete J. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacol. 1974; 11: 151.
21. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978; 186: 189.
22. Luck H. Methods of Enzymatic Analysis. 1st ed. New York: Academic Press; 1971; 885-894.
23. Green LC, Wagner DA, Glogowski J, Shipper PL, et al. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal Biochem. 1982; 126: 121.
24. Hewett JA, Schultze E, Roth RA. Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest. 1992; 66: 347.
25. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress: A review. J Biomed Sci. 2000b; 7: 444.
26. Tan DX, Manchester LC, Burkhardt S, Sainz RM, et al. N1-Acetyl- N2-formy 1-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB. 2001; 15: 2294.
27. Poeggeler B, Reiter RJ, Tan DX, Chen LD, et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res. 1993; 14: 151.
28. Reiter RJ, Tan DX, Acuna-Castroviejo D, Burkhardt S, et al. Melatonin: Mechanisms and actions as an antioxidant. Curr Top Biophys. 2000a; 24: 171.
29. Kotler ML, Rodriquez C, Sainz RM, Antolin I, et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res. 1998; 24: 83.
30. Popov SS, Pashkov AN, Popova TN, Semenikhina AV, et al. Melatonin as a corrector of free radical oxidation processes during toxic damage of liver in rat. Eksp Klin Farmakol. 2007; 70: 48.
31. Haest C, Kramp WMD, Deuliker B. Intra and intermolecular cross-linking membrane proteins in intact erythrocyte and ghosts by -SH oxidizing agents. Biochem Biophys Acta. 1997; 557: 363
32. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991; 43: 109.
33. Duval DL, Miller DR, Collier J, Billings RE. Characterization of hepatic nitric oxide synthase: identification as the cytokine inducible form primarily regulated by oxidants. Mol Pharmacol. 1996; 50: 277.
34. Roland CR, Naziruddin B, Mohanakumar T, Fiye MW. Gadolinium chloride inhibits Kupffer cell nitric oxide synthase (iNOS) induction. J Leukoc Bio. 1996; 60: 487.
35. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Over expression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anti cancer drugs, and ionizing radiation. FASEB. 1993; 7: 361.
36. Chanana V, Majumdar S, Rishi P. Involvement of caspase-3, lipid peroxidation and TNF-alpha in causing apoptosis of macrophages by coordinately expressed Salmonella phenotype under stress conditions. Mol Immunol. 2003; 44: 1551.
37. Song K, Chen Y, Goke R, Wilmen A, et al. Tumor necrosis factor related apoptosis inducing ligand (TRAIL) is an inhibitor of autoimmunity, inflammation and cell cycle progression. J Exp Med. 2000; 191: 1095.
38. Suchuerwegh AJ, Dombrecht EJ, Stevens WJ, Vanoffel JF, et al. Influence of pro-inflammatory (IL-1, IL-6, TNF-α, IFN-γ) and anti-inflammatory IL-4 cytokines on chondriocyte function. Osteoarthritis Cartilage. 2003; 11: 681.